Eosinophilic peritonitis induced by sucroferric oxyhydroxide

Perit Dial Int. 2020 Jul;40(4):419-421. doi: 10.1177/0896860820915019. Epub 2020 Mar 27.

Abstract

A 49-year-old woman developed eosinophilic peritonitis 2 months after starting continuous ambulatory peritoneal dialysis because of congenital right kidney hypoplasia and chronic glomerulonephritis. This was shown to have been induced by sucroferric oxyhydroxide, an iron-based phosphate binder, using a drug-induced lymphocyte stimulation test. Her eosinophilic peritonitis was improved after stopping the administration of sucroferric oxyhydroxide without providing any immunosuppressive agents.

Keywords: Eosinophilic peritonitis; peritoneal dialysis; sucroferric oxyhydroxide.

Publication types

  • Case Reports

MeSH terms

  • Drug Combinations
  • Eosinophilia / etiology*
  • Female
  • Ferric Compounds / adverse effects*
  • Humans
  • Hyperphosphatemia / drug therapy*
  • Hyperphosphatemia / etiology
  • Kidney / abnormalities*
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritonitis / etiology*
  • Sucrose / adverse effects*

Substances

  • Drug Combinations
  • Ferric Compounds
  • sucroferric oxyhydroxide
  • Sucrose